Parallax Announces International Medical Supply Chain Agreement for COVID-19 Testing Kits and FDA Registered Suppliers of Personal Protective Equipment (PPE)
30 mars 2020 07h00 HE
|
Parallax Health Sciences, Inc.
Joint Venture Procures from Established Manufacturers with Reliable Supply and Logistics for US Medical Operations NEW YORK, NY, March 30, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Parallax...
Parallax Launches Secure Good Health Outcomes Telehealth Application for Immediate Free Download
25 mars 2020 07h00 HE
|
Parallax Health Sciences, Inc.
Parallax Announces Patented Telehealth Initiative to Help Healthcare Providers Better Communicate with Their Patients and Reduce ER Admissions NEW YORK, NY, March 25, 2020 (GLOBE NEWSWIRE) --...
Parallax Announces Immediate Availability Point-of-Care COVID-19 Diagnostic Testing Kits, Personal Protection Equipment (PPE) and Medical Supplies
23 mars 2020 07h00 HE
|
Parallax Health Sciences, Inc.
Company Benefits from Unique Chinese, Hong Kong, Macau Diagnostic Patent Rights, and Closes Deal to Help America Now NEW YORK, NY, March 23, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Parallax...
Harvard In Tech and Parallax Health Sciences to Present Live Webinar “COVID-19 Testing, Telehealth, Technology and Data Driven Solutions” Wednesday, March 18th at 1 PM EDT
17 mars 2020 07h00 HE
|
Parallax Health Sciences, Inc.
NEW YORK, NY, March 17, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE ‒ Parallax Health Sciences, Inc. (OTCQB: PRLX) (''Parallax'' or the ''Company''), an outcome-driven connected healthcare company,...
Parallax Receives Approval on its Registration Into U.S. Government's System for Award Management, (SAM)
16 mars 2020 07h00 HE
|
Parallax Health Sciences, Inc.
Patented and FDA Approved Diagnostics Platform Subject of Application for Contract Grant with U.S. Center for Disease Control, (CDC) NEW YORK, NY, March 16, 2020 (GLOBE NEWSWIRE) -- via...
Parallax Health Management Announces Immediate Availability of its Good Health Outcomes Remote Patient Monitoring Mobile Application for Doctors and Their Patients Within the United States
12 mars 2020 07h00 HE
|
Parallax Health Sciences, Inc.
$8.3 Billion in Federal Emergency Funding from U.S. Congress Combined with Private Insurance Reimbursement Commitments Gives Boost to Telehealth Programs Addressing the COVID-19 Pandemic NEW...
Parallax Diagnostics Announces Intent to Develop a Rapid Screening Test for COVID-19 on its Patented FDA 510(K) Approved Diagnostic Platform
11 mars 2020 07h00 HE
|
Parallax Health Sciences, Inc.
Company will Partner to Accelerate The Deployment of Diagnostic Solutions Under Patent Protected Service Areas Including China, Hong Kong, India, and US NEW YORK, NY, March 11, 2020 (GLOBE...
Parallax Provides Mid-Quarter Update
24 févr. 2020 07h00 HE
|
Parallax Health Sciences, Inc.
Company Eliminates $25 Million Contingent Liability and Focuses Toward Operating Growth Parallax Licensing Program Moving Forward on All Fronts NEW YORK, NY, Feb. 24, 2020 (GLOBE NEWSWIRE) -- via...
Parallax Good Health Outcomes Mobile Application for Remote Patient Monitoring Now Available to Over 300,000 Patients in North America Through Existing Agreements
10 févr. 2020 07h00 HE
|
Parallax Health Sciences, Inc.
Critical Access Hospitals, Doctor Offices and Nursing Operations Contract with Parallax for Chronic Disease Management Capitalizing on New Reimbursement Landscape NEW YORK, NY, Feb. 10, 2020 (GLOBE...
Parallax Health Sciences Engages Alston & Bird
02 janv. 2020 07h00 HE
|
Parallax Health Sciences, Inc.
New York, NY, Jan. 02, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Parallax Health Sciences, Inc. (OTCQB: PRLX) (“Parallax”), an outcome-driven connected healthcare company, today announced that it...